Dolutegravir/Rilpivirine

dolutegravir and rilpivirine · ViiV Healthcare

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dolutegravir/Rilpivirine, covering 2024-10-16 to 2024-10-16. Get the full timeline:

Most recent: Clinical Trial Update: Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1

See pricing